New England BioLabs, Inc.

101 articles with New England BioLabs, Inc.

• New England Biolabs® Introduces NEBNext® Custom RNA Depletion Design Tool and RNA Depletion Core Reagent Set for Customizable RNA Depletion

  12/1/2020

  Combination of free user-friendly web tool, to obtain custom probe sequences, and enzyme-based technology allows for efficient depletion of abundant RNAs for virtually any organism and sample type.

• New England Biolabs® broadens its Monarch® portfolio with high molecular weight (HMW) DNA extraction kits for long-read sequencing

  11/10/2020

  New additions provide genomics researchers with improved extraction methods for ultra HMW DNA, with reduced time and increased purity, from a wide variety of biological samples

• New England Biolabs Expands its Luna® Portfolio with One-Step Master Mix for Multiplex RT-qPCR

  10/1/2020

  The new Luna Probe One-Step RT-qPCR 4X Mix with UDG enables minimal sample handling, efficient performance and sensitive detection of up to five target RNA sequences, including those of low abundance for pathogen detection.   [01-October-2020]   IPSWICH, Mass. , Oct. 1, 2020 /PRNewswire/ -- New England Biolabs ® (NEB ® ) today announced the launch of its Luna Probe One-S

• New England Biolabs' SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Novel Coronavirus In 30 Minutes

  7/10/2020

  New England Biolabs ® (NEB ® ) today announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the detection of novel coronavirus, SARS-CoV

• 

  Genetown Hotbed: Churning Along During the COVID-19 Pandemic

  3/31/2020

  As the biopharma industry responds to the COVID-19 pandemic, some of the area's companies are at the very frontlines of drug development against the disease, while others play supporting roles for the entire industry. Here's a look.

• New England Biolabs® to Showcase Next Generation Sequencing Sample Preparation Innovations at AGBT™ 2020

  2/21/2020

  Data will be presented on new and upcoming technologies, including a range of RNA depletion solutions, new Enzymatic Methyl-seq (EM-seq™) applications, new technologies for long-read sequencing applications and updates for RNA-seq workflows, including UMIs (Unique Molecular Indices).

• New England Biolabs® Announces the Donald G. Comb Honorary Lectureship Series in Celebration of Company Founder

  11/18/2019

  Featuring pioneers in molecular biology, inaugural lecture to take place on November 20th, 2019.

• New England Biolabs®, Inc. opens eighth subsidiary in Australia

  7/3/2019

  New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd.

• 

  Paper Outlines New Thinking and Knowledge of CRISPR and Off-Target Analysis

  6/19/2019

  When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-us...

• Bioz Has Partnered With NEB to Empower Life Science Researchers

  6/13/2019

  Bioz, Inc., a Silicon Valley AI data company, is proud to announce a new partnership with the world leader in the discovery and production of enzymes for molecular biology applications: New England Biolabs®.

• New England Biolabs® expands its Monarch Nucleic Acid Purification portfolio with a genomic DNA extraction and purification kit

  5/15/2019

  A comprehensive solution for cell lysis, RNA removal and purification of intact genomic DNA from a wide variety of biological samples, including, but not limited to, cultured cells, blood and mammalian tissues.

• New England Biolabs® Launches NEBNext® Enzymatic Methyl-seq (EM-seq™) for Bisulfite-Free Methylation Analysis

  4/29/2019

   New England Biolabs (NEB®) today announced the launch of NEBNext® Enzymatic Methyl-seq (EM-seq™), an enzyme-based alternative to bisulfite sequencing for methylation analysis.

• New England Biolabs® Announces 2019 Passion in Science Awards® Recipients

  4/3/2019

   New England Biolabs, Inc. (NEB®), today announced the winners of its third Passion in Science Awards, which acknowledge scientists for their innovative work that goes above and beyond the boundaries of pure science to make a profound impact on other fields, including the arts, humanitarian service, environmental stewardship, and science mentorship.

• New England Biolabs® to Present Latest NGS Sample Preparation Technology Innovations at AGBT™ 2019

  2/27/2019

  NEB® scientists, collaborators and customers to showcase data on new and upcoming NEBNext® technologies, including an enzymatic alternative to bisulfite sequencing for methylome analysis, expanded target enrichment and RNA depletion offerings, and a convenient new option for NEBNext reagents used in Oxford Nanopore Technologies® library preparation.

• New England Biolabs® Launches NEBNext Direct® Custom Ready Panels for Efficient Targeted Re-sequencing

  7/10/2018

  Library of ~850 pre-synthesized gene targets and novel target enrichment technology supports rapid customization across a variety of panel sizes and content

• New England Biolabs® Launches New NEBNext® Single Cell/Low Input RNA Library Prep Kit for Increased Transcript Detection with Ultra-low Input Amounts

  6/14/2018

  New England Biolabs (NEB®) announced the release of the NEBNext® Single Cell/Low Input RNA Library Prep Kit for Illumina®.

• New England Biolabs® Scientists Push the Limits of Golden Gate Assembly

  6/11/2018

  New publication maps ligase fidelity profiles with single molecule real-time sequencing to enable 20+ fragment assemblies with high efficiency and accuracy

• New England Biolabs® Launches "Lessons from Lab & Life™" Podcast

  4/5/2018

  Monthly episodes feature intimate conversations between scientific colleagues on science, careers and backstories that changed their lives; now available on iTunes.

• New England Biolabs Supports Creation of LabCentral Learning Lab

  1/18/2018

  Recognizing that tomorrow's innovation relies on exposing the next generation to why science matters today, New England BioLabs has become the primary sponsor of the LabCentral Learning Lab.

• New England Biolabs and CasZyme Collaborate to Enable Genome Editing Applications With Novel Cas9 Enzymes

  12/5/2017

  Under the terms of the agreement, CasZyme and NEB will apply their enzymology expertise to identify and characterize Cas nucleases.